For allogeneic hematopoietic stem cell transplantation (allo-HSCT) recipients, preemptive interferon-α (IFN-α) therapy is considered as a useful method to eliminate the minimal residual disease (MRD).
IntroductionPoor graft function (PGF) represents a serious and potentially life-threatening complication following allogeneic hematopoietic stem cell transplantation (allo-HSCT); however, its etiologi
Multivariate analysis of OS in C1-negative patients transplanted with a KIR2DS1/2/3/5 or KIR3DS1 positive donor vs. C1-negative patients transplanted with a KIR2DS1/2/3/5 or KIR3DS1 negative donor.
